Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis.

Zaidi AS, Peterson GM, Bereznicki LRE, et al. Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis. Ann Pharmacother. 2021;55(4):530-542. doi: 10.1177/1060028020949125.

Save
Print
July 21, 2021
Zaidi AS, Peterson GM, Bereznicki LRE, et al. Ann Pharmacother. 2021;55(4):530-542.
View more articles from the same authors.

Prior research has found that polypharmacy among elderly patients with dementia is associated with greater risk of functional decline. This meta-analysis of five studies concluded that exposure to potentially inappropriate medications (PIM) was not associated with either mortality or hospitalization for patients with cognitive impairment.

Save
Print
Cite
Citation

Zaidi AS, Peterson GM, Bereznicki LRE, et al. Outcomes of medication misadventure among people with cognitive impairment or dementia: a systematic review and meta-analysis. Ann Pharmacother. 2021;55(4):530-542. doi: 10.1177/1060028020949125.

Related Resources From the Same Author(s)
Related Resources